Form 8-K - Current report:
SEC Accession No. 0001558370-24-009629
Filing Date
2024-06-28
Accepted
2024-06-28 17:00:52
Documents
14
Period of Report
2024-06-28
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20240628x8k.htm   iXBRL 8-K 31131
  Complete submission text file 0001558370-24-009629.txt   159004

Data Files

Seq Description Document Type Size
2 EX-101.SCH cydy-20240628.xsd EX-101.SCH 3405
3 EX-101.LAB cydy-20240628_lab.xml EX-101.LAB 16919
4 EX-101.PRE cydy-20240628_pre.xml EX-101.PRE 11938
17 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240628x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 241086634
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)